Novo Nordisk announced it is making the popular weight loss medication available to three telehealth companies and revealed plans to make it more affordable for those paying out-of-pocket.

Shares of Hims & Hers Health (NYSE:HIMS) climbed ~34% in the premarket on Tuesday after the telehealth company announced a ...

Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Novo is expanding its direct-to-consumer efforts around its obesity drug Wegovy, partnering with telehealth companies ...

Starting a telehealth business is an exciting venture, but it comes with its own set of challenges, none more daunting than ...

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of ...

Telemedicine use in 2023 reduced monthly carbon dioxide emissions by the equivalent of more than 130,000 exhaust-spewing ...

Telemedicine is transforming post-surgical recovery, offering safer and more convenient care that improves access, and ...

Telemedicine has grown exponentially. While it has its issues, when appropriate, it has allowed patients to be treated for an ...